FDA Asks Institute Of Medicine To Evaluate 510(k) Review Process
This article was originally published in The Gray Sheet
Executive Summary
FDA has commissioned the Institute of Medicine to assess its 510(k) pre-market review process for medical devices and help determine how the oft-criticized program can be improved, the agency announced Sept. 23
You may also be interested in...
CDRH To Abandon Bad Precedents On Path To Predictable 510(k)s
FDA's device center wants to make the 510(k) process more predictable, but one of the first steps to accomplishing this is to break from what CDRH acknowledges are some questionable past decisions, according to a top Office of Device Evaluation official
CDRH To Abandon Bad Precedents On Path To Predictable 510(k)s
FDA's device center wants to make the 510(k) process more predictable, but one of the first steps to accomplishing this is to break from what CDRH acknowledges are some questionable past decisions, according to a top Office of Device Evaluation official
CDRH Acting Director Jeffrey Shuren Vies For Permanent Spot
Acting device center director Jeffrey Shuren is vying to head the center permanently. He announced his candidacy to agency staff last week, according to Principal Deputy FDA Commissioner Joshua Sharfstein